Evidence map›Paper›PMID 40988674›Full record

ArticleFrontiers in public health2025

Antimicrobial resistance in the Eastern Mediterranean Region: experiences, challenges, and perspectives.

Deema Al Bakri, Maya Joukhadar, Aamer Ikram, Nelea Motriuc, Ghassan M Matar, Rola Ali Ghanem, Heba Mahrous, Tariq Hassan Taha, Hafiz Ahmad, Priyalatha Muthu and 5 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Deema Al BakriThe East Mediterranean Public Health Network, Amman, Jordan.
Maya JoukhadarDiakonie Katastrophenhilfe, Amman, Jordan.
Aamer IkramHealth Fauji Foundation, Islamabad, Pakistan.
Nelea MotriucAMR Multi-Stakeholder Partnership Platform, Quadripartite, Rome, Italy.
Ghassan M MatarDepartment of Experimental Pathology, Immunology, and Microbiology, American University of Beirut, WHO Collaborating Center, Beirut, Lebanon.
Rola Ali GhanemCRDF, Amman, Jordan.
Heba MahrousWorld Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Tariq Hassan TahaWorld Organization for Animal Health Subregional Representation for the Arabian Gulf, Abu Dhabi, United Arab Emirates.
Hafiz AhmadRAK Medical & Health Sciences University, Ras Al-Khaimah, United Arab Emirates.
Priyalatha MuthuRAK Medical & Health Sciences University, Ras Al-Khaimah, United Arab Emirates.
Ibrahim Al FaouriRAK Medical & Health Sciences University, Ras Al-Khaimah, United Arab Emirates.
Haitham BashierThe East Mediterranean Public Health Network, Amman, Jordan.
Magid Al-GunaidPolio and Immunization Unite, Public Health Department, The Eastern Mediterranean Public Health Network, Amman, Jordan.
Mohannad Al NsourThe East Mediterranean Public Health Network, Amman, Jordan.
Yousef KhaderDepartment of Public Health, Jordan University of Science and Technology, Irbid, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a rapidly growing global health threat that undermines the effectiveness of first-line treatments for serious infectious diseases. During the Eighth Regional Conference of the Eastern Mediterranean Public Health Network (EMPHNET), held in Amman, Jordan, from September 15-18, 2024, this critical issue took center stage under the theme "Advancing Public Health Preparedness and Response." A dedicated roundtable discussion on AMR explored the challenges of implementing effective AMR surveillance, the widespread misuse of antibiotics, and the urgent need for a One Health approach that integrates human, animal, and environmental health. Speakers emphasized that political commitment, sustainable funding, and cross-sector collaboration are essential to curbing AMR, particularly in the Eastern Mediterranean Region (EMR), where factors such as high antimicrobial consumption, conflict, weak health systems, and poor access to regulated antibiotics exacerbate the problem. The discussion also highlighted the critical roles of laboratories and infection prevention and control (IPC) programs in healthcare settings, both of which are central to AMR surveillance and stewardship. Global efforts, including the WHO's Global Action Plan on AMR and the AMR Multi-Stakeholder Partnership Platform, were recognized as vital frameworks for fostering international cooperation and guiding regional responses. The roundtable concluded with a call for strengthened governance, enhanced laboratory capacities, improved surveillance systems, scaling up IPC programs and enhanced public awareness campaigns to confront the rising threat of AMR in the EMR.

Indexed as

Anti-Bacterial AgentsDrug Resistance, MicrobialPublic HealthHumansMediterranean RegionOne HealthAnti-Bacterial Agentsantimicrobial resistance (AMR)antimicrobial stewardshipEastern Mediterranean Regioninfection prevention and controlnational action plans

Identifiers

PMID40988674
PMCPMC12450941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.